Agranular CD4+ CD56+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 Cases;Localisations cutanées révélatrices d'une hématodermie CD4+ CD56+ CD123+: 2 Cas

Annales de Dermatologie et de Venereologie

Volumn 131, Issue 11, 2004, Pages 969-973

  Machet, L ^a   De Muret, A ^a   Wiezberka, E ^a   Bernez, A ^a   Abdallah Lotf, M ^a   Linassier, C ^a   Petrella, T ^b  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b Centre de Pathologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD123 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; T LYMPHOCYTE RECEPTOR;

AGED; ANTIGEN EXPRESSION; ARTICLE; BONE; BRAIN; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER REGRESSION; CASE REPORT; CELL SIZE; CIRCULATION; CONSULTATION; DEATH; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; PATIENT REFERRAL; SKIN BIOPSY; SKIN LYMPHOMA; THROMBOCYTOPENIA;

EID: 10644263206     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(04)93807-0     Document Type: Article

References (14)

1. Petrella T, Dalac S, Maynadie M, Mugneret F, Thomine E, Courville P et al. CD4+ CD56+ cutaneous neoplasms: a distinct haematological entity? Am J Surg Pathol 1999;23:137-46.
2. Petrella T, Comeau MR, Maynadie M, Couillault G, De Muret A, Maliszewski CR, et al. Agranular CD4+ CD56+ hematodermic neoplasm (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002; 26:852-62.
3. Child FJ, Mitchell TJ, Whittaker SJ, Calonje E, Spittle M, Crocker J, et al. Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the U.K. Br J Dermatol 2003;148:507-15.
4. Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D. CD56 (+) TdT (+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer 2002; 94:2401-8.
5. Feuillard J, Jacob MC, Valensi F, Maynadie M, Gressin R, Chaperot L, et al. Clinical and biologic features of CD4 (+) CD56 (+) malignancies. Blood 2002;99:1556-63.
6. Reimer P, Rudiger T, Kraemer D, Kunzmann V, Weissinger F, Zettl A, et al. What is CD4+ CD56+ malignancy and how should it be treated? Bone Marrow Transplant 2003;32:637-46.
7. Chan JKC, Jaffe ES, Ralfkiaer E. Blastic NK-cell lymphoma. In: The WHO classification of tumors: tumors of the hematopoietic and lymphoid tissues (Jaffe ES, Harris NL, Stein H, Vardiman JW, eds). Lyon: IARC press, 2001:214-5.
8. Petrella T, Teitell M, Spiekermann C, Meijer CJLM, Franck F, Enache I. A CD56-negative case of Blastic NK cell Lymphoma (agranular CD4+/CD56+ hematodermic neoplasm). Br J Dermatol 2004;150:174-6.
9. Chaperot L, Bendriss N, Manches O, Gressin R, Maynadié M, Trimoreau F, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001;97:3210-7.
10. Trimoreau F, Donnard M, Turlure P, Gachard N, Bordessoule D, Feuillard J. The CD4+ CD56+ CD116- CD123+ CD45RA+ CD45RO- profile is specific of DC2 malignancies Haematologica 2003;88:(03) ELT10.
11. Alonso-C LM, Munoz JJ, Zapata AG. Delineation of intrathymic T, NK and dendritic cell (DC) progenitors in fetal and adult rats: demonstration of a bipotent T/DC intermediate precursor. J Immunol 2001; 167:3635-41.
12. Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D. TCL1 Expression in plasmacytoid dendritic cells (DC2) and the related CD4+ CD56+ blastic tumors of skin. Blood 2003;101:5007-9.
13. Anargyrou K, Paterakis G, Boutsis D, Politou M, Papadhimitriou SI, Siakandaris M, et al. An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia. Eur J Haematol 2003;71:294-8.
14. Tsuchiyama J, Yoshino T, Toba K, Harada N, Nishiuchi R, Akagi T, et al. Induction and characterization of cutaneous lymphocyte antigen on natural killer cells. Br J Dermatol 2002;118:654-62.